| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 4.19e-06 | 5 | 151 | 3 | GO:0004749 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 8.34e-06 | 6 | 151 | 3 | GO:0016778 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.82e-05 | 27 | 151 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.47e-04 | 105 | 151 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.67e-04 | 17 | 151 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 3.37e-04 | 4 | 151 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | collagen binding | 3.73e-04 | 81 | 151 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.64e-04 | 24 | 151 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 9.09e-04 | 57 | 151 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.02e-03 | 207 | 151 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.05e-03 | 208 | 151 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.07e-03 | 102 | 151 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.10e-03 | 60 | 151 | 4 | GO:0099529 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate metabolic process | 7.87e-06 | 6 | 153 | 3 | GO:0046391 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate biosynthetic process | 7.87e-06 | 6 | 153 | 3 | GO:0006015 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 1.51e-05 | 107 | 153 | 7 | GO:0001657 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 1.81e-05 | 110 | 153 | 7 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 1.81e-05 | 110 | 153 | 7 | GO:0072163 | |
| GeneOntologyBiologicalProcess | mesonephros development | 2.16e-05 | 113 | 153 | 7 | GO:0001823 | |
| GeneOntologyBiologicalProcess | clathrin-dependent synaptic vesicle endocytosis | 5.47e-05 | 2 | 153 | 2 | GO:0150007 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.18e-04 | 198 | 153 | 8 | GO:0048754 | |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 3.88e-06 | 5 | 154 | 3 | GO:0002189 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.20e-04 | 277 | 154 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | USH2 complex | 3.20e-04 | 4 | 154 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | extracellular matrix | AMBN ADAMTS19 HSPG2 COL6A3 HTRA1 ANXA11 LAMA3 LINGO2 TGFBI LINGO1 CD180 USH2A PLXNA2 LRRC15 | 3.63e-04 | 656 | 154 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | AMBN ADAMTS19 HSPG2 COL6A3 HTRA1 ANXA11 LAMA3 LINGO2 TGFBI LINGO1 CD180 USH2A PLXNA2 LRRC15 | 3.74e-04 | 658 | 154 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | inclusion body | 5.40e-04 | 90 | 154 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | non-motile cilium | 6.37e-04 | 196 | 154 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 7.93e-04 | 6 | 154 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 7.93e-04 | 6 | 154 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 7.93e-04 | 6 | 154 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 7.93e-04 | 6 | 154 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | presynapse | SGTA ITSN1 BACE1 GRIA1 GRIA4 GRM4 LINGO1 NRXN2 TRIM9 GLRA1 ITSN2 SLC6A5 GRIN3A SEPTIN7 DNMBP USH2A | 8.57e-04 | 886 | 154 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | axon | EXOC6 MAP1A ITSN1 GARS1 BACE1 GRIA1 GRIA4 PLXND1 RET GRM4 ARMCX3 GLRA1 SBF2 WDFY3 SEPTIN7 USH2A | 9.09e-04 | 891 | 154 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 9.61e-04 | 153 | 154 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | midbody | 1.32e-03 | 222 | 154 | 7 | GO:0030496 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.47e-03 | 8 | 154 | 2 | GO:0002139 | |
| Domain | PRPP_SYNTHASE | 5.50e-07 | 3 | 154 | 3 | PS00114 | |
| Domain | PRib_PP_synth_CS | 5.50e-07 | 3 | 154 | 3 | IPR000842 | |
| Domain | Pribosyltran_N | 5.43e-06 | 5 | 154 | 3 | PF13793 | |
| Domain | Pribosyl_synth | 5.43e-06 | 5 | 154 | 3 | PF14572 | |
| Domain | Rib-P_diPkinase | 5.43e-06 | 5 | 154 | 3 | IPR005946 | |
| Domain | Pribosyltran_N | 5.43e-06 | 5 | 154 | 3 | IPR029099 | |
| Domain | - | 1.36e-05 | 95 | 154 | 7 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.41e-05 | 219 | 154 | 10 | IPR013320 | |
| Domain | LAM_G_DOMAIN | 1.44e-05 | 38 | 154 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 1.86e-05 | 40 | 154 | 5 | PF02210 | |
| Domain | LamG | 2.99e-05 | 44 | 154 | 5 | SM00282 | |
| Domain | DUF3697_Uba2 | 6.75e-05 | 2 | 154 | 2 | IPR022166 | |
| Domain | PH_13 | 6.75e-05 | 2 | 154 | 2 | PF16652 | |
| Domain | DUF3697 | 6.75e-05 | 2 | 154 | 2 | PF12478 | |
| Domain | Pribosyltran | 8.64e-05 | 11 | 154 | 3 | PF00156 | |
| Domain | UBA | 1.03e-04 | 30 | 154 | 4 | SM00165 | |
| Domain | PRTase-like | 1.15e-04 | 12 | 154 | 3 | IPR029057 | |
| Domain | PRibTrfase_dom | 1.15e-04 | 12 | 154 | 3 | IPR000836 | |
| Domain | - | 1.15e-04 | 12 | 154 | 3 | 3.40.50.2020 | |
| Domain | Laminin_G | 1.15e-04 | 58 | 154 | 5 | IPR001791 | |
| Domain | UBA | 2.13e-04 | 36 | 154 | 4 | PF00627 | |
| Domain | Peripla_BP_I | 2.92e-04 | 39 | 154 | 4 | IPR028082 | |
| Domain | Retinoic_acid_rcpt | 4.01e-04 | 4 | 154 | 2 | IPR003078 | |
| Domain | Lig_chan-Glu_bd | 4.10e-04 | 18 | 154 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 4.10e-04 | 18 | 154 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 4.10e-04 | 18 | 154 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 4.10e-04 | 18 | 154 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 4.10e-04 | 18 | 154 | 3 | IPR001508 | |
| Domain | Lig_chan | 4.10e-04 | 18 | 154 | 3 | PF00060 | |
| Domain | PBPe | 4.10e-04 | 18 | 154 | 3 | SM00079 | |
| Domain | UBQ | 4.27e-04 | 43 | 154 | 4 | SM00213 | |
| Domain | UBA | 4.67e-04 | 44 | 154 | 4 | IPR015940 | |
| Domain | ubiquitin | 6.02e-04 | 47 | 154 | 4 | PF00240 | |
| Domain | UBA | 6.02e-04 | 47 | 154 | 4 | PS50030 | |
| Domain | Ig-like_fold | FNDC3B HSPG2 COL6A3 HLA-DPA1 SIGLEC14 LINGO2 PLXND1 LILRB1 LINGO1 TRIM9 PKHD1 SEMA4A USH2A PLXNA2 IGSF23 | 7.51e-04 | 706 | 154 | 15 | IPR013783 |
| Domain | Ubiquilin | 9.91e-04 | 6 | 154 | 2 | IPR015496 | |
| Domain | UBIQUITIN_2 | 1.02e-03 | 54 | 154 | 4 | PS50053 | |
| Domain | - | FNDC3B HSPG2 COL6A3 HLA-DPA1 SIGLEC14 LINGO2 PLXND1 LILRB1 LINGO1 TRIM9 PKHD1 USH2A PLXNA2 IGSF23 | 1.20e-03 | 663 | 154 | 14 | 2.60.40.10 |
| Domain | Ubiquitin_dom | 1.33e-03 | 58 | 154 | 4 | IPR000626 | |
| Domain | IPT | 1.39e-03 | 27 | 154 | 3 | SM00429 | |
| Domain | LAMININ_IVA | 1.83e-03 | 8 | 154 | 2 | PS51115 | |
| Domain | Laminin_B | 1.83e-03 | 8 | 154 | 2 | PF00052 | |
| Domain | LamB | 1.83e-03 | 8 | 154 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.83e-03 | 8 | 154 | 2 | IPR000034 | |
| Domain | EGF_LAM_2 | 1.90e-03 | 30 | 154 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.90e-03 | 30 | 154 | 3 | PS01248 | |
| Domain | UBA-like | 1.92e-03 | 64 | 154 | 4 | IPR009060 | |
| Domain | Semap_dom | 2.09e-03 | 31 | 154 | 3 | IPR001627 | |
| Domain | SEMA | 2.09e-03 | 31 | 154 | 3 | PS51004 | |
| Domain | TIG | 2.09e-03 | 31 | 154 | 3 | PF01833 | |
| Domain | Sema | 2.09e-03 | 31 | 154 | 3 | SM00630 | |
| Domain | Sema | 2.09e-03 | 31 | 154 | 3 | PF01403 | |
| Domain | IPT | 2.29e-03 | 32 | 154 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 2.29e-03 | 32 | 154 | 3 | IPR002165 | |
| Domain | PSI | 2.29e-03 | 32 | 154 | 3 | PF01437 | |
| Domain | Plexin_cytopl | 2.34e-03 | 9 | 154 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.34e-03 | 9 | 154 | 2 | IPR013548 | |
| Domain | Plexin | 2.34e-03 | 9 | 154 | 2 | IPR031148 | |
| Domain | RhoGEF | 2.40e-03 | 68 | 154 | 4 | SM00325 | |
| Domain | RhoGEF | 2.67e-03 | 70 | 154 | 4 | PF00621 | |
| Domain | DH_2 | 2.67e-03 | 70 | 154 | 4 | PS50010 | |
| Domain | - | 2.81e-03 | 71 | 154 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 2.81e-03 | 71 | 154 | 4 | IPR000219 | |
| Domain | STI1 | 2.91e-03 | 10 | 154 | 2 | SM00727 | |
| Domain | EF-hand_4 | 2.91e-03 | 10 | 154 | 2 | PF12763 | |
| Domain | STI1_HS-bd | 2.91e-03 | 10 | 154 | 2 | IPR006636 | |
| Domain | EGF_Lam | 2.97e-03 | 35 | 154 | 3 | SM00180 | |
| Domain | Laminin_EGF | 2.97e-03 | 35 | 154 | 3 | PF00053 | |
| Domain | ANF_lig-bd_rcpt | 3.48e-03 | 37 | 154 | 3 | IPR001828 | |
| Domain | ANF_receptor | 3.48e-03 | 37 | 154 | 3 | PF01094 | |
| Domain | UBIQUITIN_1 | 3.48e-03 | 37 | 154 | 3 | PS00299 | |
| Domain | EH | 3.54e-03 | 11 | 154 | 2 | PS50031 | |
| Domain | EH | 3.54e-03 | 11 | 154 | 2 | SM00027 | |
| Domain | EH_dom | 3.54e-03 | 11 | 154 | 2 | IPR000261 | |
| Domain | Laminin_EGF | 3.75e-03 | 38 | 154 | 3 | IPR002049 | |
| Domain | SH3_9 | 3.95e-03 | 78 | 154 | 4 | PF14604 | |
| Domain | SH3_2 | 5.59e-03 | 86 | 154 | 4 | PF07653 | |
| Domain | SH3_2 | 5.59e-03 | 86 | 154 | 4 | IPR011511 | |
| Domain | PSI | 5.68e-03 | 44 | 154 | 3 | IPR016201 | |
| Domain | PSI | 6.44e-03 | 46 | 154 | 3 | SM00423 | |
| Domain | Cys-rich_flank_reg_C | 6.56e-03 | 90 | 154 | 4 | IPR000483 | |
| Domain | LRRCT | 6.56e-03 | 90 | 154 | 4 | SM00082 | |
| Domain | BAR | 6.61e-03 | 15 | 154 | 2 | SM00721 | |
| Domain | Spectrin_alpha_SH3 | 6.61e-03 | 15 | 154 | 2 | IPR013315 | |
| Domain | BAR | 6.61e-03 | 15 | 154 | 2 | PF03114 | |
| Domain | AAA | 6.87e-03 | 144 | 154 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 6.87e-03 | 144 | 154 | 5 | IPR003593 | |
| Domain | Laminin_N | 7.51e-03 | 16 | 154 | 2 | IPR008211 | |
| Domain | BAR_dom | 7.51e-03 | 16 | 154 | 2 | IPR004148 | |
| Domain | LamNT | 7.51e-03 | 16 | 154 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 7.51e-03 | 16 | 154 | 2 | PS51117 | |
| Domain | Laminin_N | 7.51e-03 | 16 | 154 | 2 | PF00055 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 1314091 | ||
| Pubmed | UBAP2 VWA8 HECTD4 SPART PLXND1 KEAP1 ADGRV1 CLOCK EFR3A NRXN2 TRIM9 SCFD1 EDEM1 DNMBP | 1.43e-07 | 529 | 157 | 14 | 14621295 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 2.77e-07 | 13 | 157 | 4 | 20859245 | |
| Pubmed | UBAP2 ITSN1 DLGAP4 HECTD4 SH3BP1 GRIA1 GRIA4 KEAP1 SMC2 GRM4 DDX3X IGF2R UBAP2L EIF4G1 WDFY3 SEPTIN7 CDH11 LRRC15 | 4.03e-07 | 963 | 157 | 18 | 28671696 | |
| Pubmed | Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. | 8.97e-07 | 5 | 157 | 3 | 12195422 | |
| Pubmed | Vitamin A controls epithelial/mesenchymal interactions through Ret expression. | 8.97e-07 | 5 | 157 | 3 | 11138002 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.67e-06 | 179 | 157 | 8 | 36261009 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 24699546 | ||
| Pubmed | 2.22e-06 | 130 | 157 | 7 | 12421765 | ||
| Pubmed | Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex. | 3.12e-06 | 7 | 157 | 3 | 22988142 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 3.96e-06 | 24 | 157 | 4 | 35746896 | |
| Pubmed | 4.80e-06 | 95 | 157 | 6 | 20843830 | ||
| Pubmed | 5.72e-06 | 150 | 157 | 7 | 32423001 | ||
| Pubmed | 6.09e-06 | 99 | 157 | 6 | 31723608 | ||
| Pubmed | Stromal cells mediate retinoid-dependent functions essential for renal development. | 1.06e-05 | 10 | 157 | 3 | 10021334 | |
| Pubmed | Reduced BMP4 abundance in Gata2 hypomorphic mutant mice result in uropathies resembling human CAKUT. | 1.45e-05 | 11 | 157 | 3 | 18233958 | |
| Pubmed | 1.59e-05 | 117 | 157 | 6 | 17145500 | ||
| Pubmed | 1.93e-05 | 12 | 157 | 3 | 25839327 | ||
| Pubmed | Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation. | 2.02e-05 | 2 | 157 | 2 | 29921692 | |
| Pubmed | LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein. | 2.02e-05 | 2 | 157 | 2 | 36735681 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 37603735 | ||
| Pubmed | Clock gene Per3 deficiency disrupts circadian alterations of gut microbiota in mice. | 2.02e-05 | 2 | 157 | 2 | 37964605 | |
| Pubmed | LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. | 2.02e-05 | 2 | 157 | 2 | 20369371 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 1330302 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 31031201 | ||
| Pubmed | Intersectin associates with synapsin and regulates its nanoscale localization and function. | 2.02e-05 | 2 | 157 | 2 | 29078407 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19967263 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36228039 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36757924 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 18840692 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23592924 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 24833708 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23447614 | ||
| Pubmed | Semaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner. | 2.02e-05 | 2 | 157 | 2 | 32971928 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 8631863 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 31813992 | ||
| Pubmed | Epistasis between IGF2R and ADAMTS19 polymorphisms associates with premature ovarian failure. | 2.02e-05 | 2 | 157 | 2 | 24014609 | |
| Pubmed | Circadian rhythm genes CLOCK and PER3 polymorphisms and morning gastric motility in humans. | 2.02e-05 | 2 | 157 | 2 | 25775462 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 7644503 | ||
| Pubmed | The human intersectin genes and their spliced variants are differentially expressed. | 2.02e-05 | 2 | 157 | 2 | 11690630 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 31197037 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 32737280 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 35633597 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12524348 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 15671307 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 34638692 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 20364331 | ||
| Pubmed | DDX3 regulates endoplasmic reticulum stress-induced ATF4 expression. | 2.02e-05 | 2 | 157 | 2 | 29062139 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 18409517 | ||
| Pubmed | Measures of anxiety, sensorimotor function, and memory in male and female mGluR4⁻/⁻ mice. | 2.02e-05 | 2 | 157 | 2 | 22227508 | |
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 2.02e-05 | 2 | 157 | 2 | 28653555 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 9168777 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22155582 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 37996967 | ||
| Pubmed | Genomic landscape of retinoblastoma in Rb-/- p130-/- mice resembles human retinoblastoma. | 2.02e-05 | 2 | 157 | 2 | 27750399 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 1334013 | ||
| Pubmed | PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness. | 2.02e-05 | 2 | 157 | 2 | 33493137 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23936226 | ||
| Pubmed | Clock genes associate with white matter integrity in depressed bipolar patients. | 2.02e-05 | 2 | 157 | 2 | 27996307 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26563932 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36847953 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 15159591 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 30601638 | ||
| Pubmed | Interaction between nuclear localization signal-retinoic acid receptor alpha and Ubiquilin 1. | 2.02e-05 | 2 | 157 | 2 | 20693704 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28780133 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 2537655 | ||
| Pubmed | Characterization of the functional role of the N-glycans in the AMPA receptor ligand-binding domain. | 2.02e-05 | 2 | 157 | 2 | 12603841 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26453284 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27306217 | ||
| Pubmed | RA-RAR-β counteracts myelin-dependent inhibition of neurite outgrowth via Lingo-1 repression. | 2.02e-05 | 2 | 157 | 2 | 21690307 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12009305 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | UBAP2 UBQLN1 MAP1A ITSN1 KEAP1 TEX14 RET TMEM132C UBQLN3 TMEM59L | 2.80e-05 | 430 | 157 | 10 | 35044719 |
| Pubmed | 3.17e-05 | 14 | 157 | 3 | 18561907 | ||
| Pubmed | 3.24e-05 | 196 | 157 | 7 | 19334288 | ||
| Pubmed | 3.42e-05 | 81 | 157 | 5 | 22723691 | ||
| Pubmed | 3.55e-05 | 41 | 157 | 4 | 30377232 | ||
| Pubmed | Proteomic analysis of an interactome for long-form AMPA receptor subunits. | 3.95e-05 | 15 | 157 | 3 | 20131911 | |
| Pubmed | Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. | 3.95e-05 | 15 | 157 | 3 | 9630982 | |
| Pubmed | ACAT2 PIGS ITSN1 KEAP1 DDOST IGF2R UBAP2L EIF4G1 SCFD1 WIPI2 | 4.03e-05 | 449 | 157 | 10 | 31732153 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 MAN2A2 CLTCL1 VWA8 CTC1 ANXA11 HECTD4 PEX6 PLXND1 RYR1 IGF2R SBF2 EIF4G1 SORBS3 WDFY3 DNMBP | 4.34e-05 | 1105 | 157 | 16 | 35748872 |
| Pubmed | 4.74e-05 | 142 | 157 | 6 | 30809309 | ||
| Pubmed | 4.84e-05 | 16 | 157 | 3 | 27693352 | ||
| Pubmed | 4.84e-05 | 16 | 157 | 3 | 16880404 | ||
| Pubmed | 5.99e-05 | 216 | 157 | 7 | 31519766 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 17296559 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 7607068 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 7607067 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 11172439 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 8383767 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 31718706 | ||
| Pubmed | Retinoic acid receptor gamma: specific immunodetection and phosphorylation. | 6.06e-05 | 3 | 157 | 2 | 1655807 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 30190494 | ||
| Pubmed | PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. | 6.06e-05 | 3 | 157 | 2 | 20440071 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 34112033 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 9659935 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 11245412 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 23969901 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 9366267 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 10100049 | ||
| Pubmed | Semaphorin 4A enhances lung fibrosis through activation of Akt via PlexinD1 receptor. | 6.06e-05 | 3 | 157 | 2 | 26648031 | |
| Interaction | DKKL1 interactions | 2.09e-06 | 111 | 153 | 8 | int:DKKL1 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 2.10e-04 | 4 | 108 | 2 | 1244 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 2.10e-04 | 4 | 108 | 2 | 1200 | |
| GeneFamily | Ubiquilin family | 3.49e-04 | 5 | 108 | 2 | 783 | |
| GeneFamily | Plexins | 1.24e-03 | 9 | 108 | 2 | 683 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_DN | 2.77e-06 | 17 | 157 | 4 | MM911 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_DN | 2.77e-06 | 17 | 157 | 4 | M2318 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP | 3.50e-06 | 200 | 157 | 9 | M5990 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.12e-08 | 194 | 157 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.26e-08 | 195 | 157 | 9 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.39e-07 | 193 | 157 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.75e-07 | 200 | 157 | 8 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.75e-07 | 200 | 157 | 8 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.75e-07 | 200 | 157 | 8 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | metastatic_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.75e-07 | 200 | 157 | 8 | bfb54a8ce44caf01083c6567b236395c6ee1d47a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 160 | 157 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 160 | 157 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-06 | 168 | 157 | 7 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-06 | 175 | 157 | 7 | 6a093c74a6f3daeff07759d6eec542fc5c709149 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-06 | 178 | 157 | 7 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.72e-06 | 181 | 157 | 7 | 59527ad218e49386b04cabb97d53d2ed55a35961 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 4.00e-06 | 183 | 157 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 184 | 157 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 184 | 157 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 184 | 157 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.30e-06 | 185 | 157 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-06 | 187 | 157 | 7 | 00930e407beaa337f72533a69f32d150faad8b9a | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-06 | 188 | 157 | 7 | e079a3873cf442e98ff41a240c80b80995aace11 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-06 | 189 | 157 | 7 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-06 | 189 | 157 | 7 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.12e-06 | 190 | 157 | 7 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.30e-06 | 191 | 157 | 7 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-06 | 193 | 157 | 7 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.87e-06 | 194 | 157 | 7 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.87e-06 | 194 | 157 | 7 | 449ce4167d64c170d914e0250f739eabedcf915d | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-06 | 195 | 157 | 7 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-06 | 195 | 157 | 7 | f9a90cd7b4e99a0947fdb3645f7787d02b0f7ca0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.28e-06 | 196 | 157 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.28e-06 | 196 | 157 | 7 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.49e-06 | 197 | 157 | 7 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-06 | 197 | 157 | 7 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-06 | 197 | 157 | 7 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-06 | 197 | 157 | 7 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.71e-06 | 198 | 157 | 7 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-06 | 198 | 157 | 7 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.71e-06 | 198 | 157 | 7 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.71e-06 | 198 | 157 | 7 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-06 | 198 | 157 | 7 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-06 | 199 | 157 | 7 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.93e-06 | 199 | 157 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.93e-06 | 199 | 157 | 7 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.93e-06 | 199 | 157 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-06 | 199 | 157 | 7 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.16e-06 | 200 | 157 | 7 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.16e-06 | 200 | 157 | 7 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Control-Control-Myeloid-CD16+_Monocyte|Control / Disease, condition lineage and cell class | 7.16e-06 | 200 | 157 | 7 | 8dd124a5aca897652ea68efbfc5a167b4cf31aef | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.61e-05 | 151 | 157 | 6 | 23b6cf9a36ad0e937f69c75921bddd305a9a526c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.61e-05 | 151 | 157 | 6 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 154 | 157 | 6 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-05 | 95 | 157 | 5 | 3d6b97576ce4e7a3e495cbc7246ea8c0b2a386f7 | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 2.31e-05 | 161 | 157 | 6 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.57e-05 | 164 | 157 | 6 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_3|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.66e-05 | 165 | 157 | 6 | a6547bb2c9c40b4878325da19b9def0ef644fa25 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-05 | 167 | 157 | 6 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 168 | 157 | 6 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 168 | 157 | 6 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 171 | 157 | 6 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 171 | 157 | 6 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-05 | 172 | 157 | 6 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-05 | 174 | 157 | 6 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.58e-05 | 174 | 157 | 6 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.69e-05 | 175 | 157 | 6 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 175 | 157 | 6 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.81e-05 | 176 | 157 | 6 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-05 | 176 | 157 | 6 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.81e-05 | 176 | 157 | 6 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 177 | 157 | 6 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.93e-05 | 177 | 157 | 6 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-05 | 180 | 157 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-05 | 110 | 157 | 5 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.46e-05 | 181 | 157 | 6 | 9b2d207dc9fc2228a1555ed360286bb7c2d988ff | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-05 | 181 | 157 | 6 | 090e89b506d945e123e647d08947e9649a65ce7c | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.60e-05 | 182 | 157 | 6 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-05 | 182 | 157 | 6 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 182 | 157 | 6 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-05 | 182 | 157 | 6 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | Mild-CD4+_T|World / Disease group and Cell class | 4.74e-05 | 183 | 157 | 6 | c4ac8893d38a3da4e19fe2ef1756bd69c89e975c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-05 | 183 | 157 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-05 | 183 | 157 | 6 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 113 | 157 | 5 | ec4b89e727e1b921b9cb17443774955b95814dd4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-05 | 185 | 157 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 185 | 157 | 6 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 185 | 157 | 6 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-05 | 186 | 157 | 6 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-05 | 186 | 157 | 6 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 186 | 157 | 6 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.19e-05 | 186 | 157 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-05 | 186 | 157 | 6 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-05 | 186 | 157 | 6 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 186 | 157 | 6 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-05 | 186 | 157 | 6 | 8ea708070166c858cd9bd871670655b0114c32a5 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.34e-05 | 187 | 157 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | CF-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 5.34e-05 | 187 | 157 | 6 | adc79e5804ab98006dbdf1d76ef0d8f85cc5cb0f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-05 | 187 | 157 | 6 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.50e-05 | 188 | 157 | 6 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.67e-05 | 189 | 157 | 6 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 5.67e-05 | 189 | 157 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.67e-05 | 189 | 157 | 6 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| Drug | benzbromarone | 1.90e-07 | 37 | 157 | 6 | CID000002333 | |
| Drug | felbamate | 5.40e-07 | 70 | 157 | 7 | CID000003331 | |
| Drug | 5,7-dichlorokynurenic acid | 1.07e-06 | 49 | 157 | 6 | CID000001779 | |
| Drug | PPNDS | 4.83e-06 | 17 | 157 | 4 | CID005961627 | |
| Drug | AC1L1AO2 | 6.18e-06 | 18 | 157 | 4 | CID000001073 | |
| Drug | methyl iodoacetate | 6.34e-06 | 6 | 157 | 3 | CID006429536 | |
| Drug | APP-MP | 6.34e-06 | 6 | 157 | 3 | CID003081102 | |
| Drug | pyrimidine-5-nucleotide | 6.34e-06 | 6 | 157 | 3 | CID000440040 | |
| Drug | kynurenic acid | 2.24e-05 | 122 | 157 | 7 | CID000003845 | |
| Drug | memantine | 2.91e-05 | 86 | 157 | 6 | CID000004054 | |
| Disease | Malignant neoplasm of breast | ADAMTS19 FNDC3B ABCA4 RARA RARB PIGS GRB7 POU2F1 KEAP1 SIX4 MAMDC4 DDX3X SLC22A9 PER3 DDX18 ITSN2 SLC6A5 PRPS1 | 1.24e-05 | 1074 | 153 | 18 | C0006142 |
| Disease | HYPEREKPLEXIA 1 | 2.67e-05 | 2 | 153 | 2 | C4551954 | |
| Disease | Cholelithiasis | 2.67e-05 | 2 | 153 | 2 | C0008350 | |
| Disease | Schizophrenia | RARA PON1 BACE1 GRIA1 GRIA4 GRM4 CLOCK LILRB1 HSPA12A NRXN2 SLC6A5 GRIN3A MSS51 SEPTIN7 PLXNA2 | 5.90e-05 | 883 | 153 | 15 | C0036341 |
| Disease | retinitis pigmentosa (is_implicated_in) | 6.06e-05 | 41 | 153 | 4 | DOID:10584 (is_implicated_in) | |
| Disease | esophageal carcinoma (is_marker_for) | 7.99e-05 | 3 | 153 | 2 | DOID:1107 (is_marker_for) | |
| Disease | cannabis dependence measurement | 1.13e-04 | 48 | 153 | 4 | EFO_0008457 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 1.23e-04 | 49 | 153 | 4 | EFO_0006954, EFO_1001069 | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 1.59e-04 | 4 | 153 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 1.59e-04 | 4 | 153 | 2 | C0751925 | |
| Disease | Sciatic Neuropathy | 1.59e-04 | 4 | 153 | 2 | C0149940 | |
| Disease | response to carbamazepine | 1.59e-04 | 4 | 153 | 2 | EFO_0008484 | |
| Disease | Lesion of Sciatic Nerve | 1.59e-04 | 4 | 153 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 1.59e-04 | 4 | 153 | 2 | C0242013 | |
| Disease | Amyotrophic Lateral Sclerosis | 2.37e-04 | 58 | 153 | 4 | C0002736 | |
| Disease | Hereditary Hyperexplexia | 2.64e-04 | 5 | 153 | 2 | C1835614 | |
| Disease | Hereditary hyperekplexia | 2.64e-04 | 5 | 153 | 2 | cv:C1835614 | |
| Disease | Hyperekplexia | 3.95e-04 | 6 | 153 | 2 | cv:C0234166 | |
| Disease | cholesteryl ester measurement | 4.04e-04 | 257 | 153 | 7 | EFO_0010351 | |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 4.52e-04 | 29 | 153 | 3 | C0393554 | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 5.51e-04 | 7 | 153 | 2 | C0399367 | |
| Disease | Amyotrophic Lateral Sclerosis, Guam Form | 5.52e-04 | 31 | 153 | 3 | C0543859 | |
| Disease | argininate measurement | 7.33e-04 | 8 | 153 | 2 | EFO_0800055 | |
| Disease | multiple myeloma (is_marker_for) | 8.61e-04 | 36 | 153 | 3 | DOID:9538 (is_marker_for) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 9.39e-04 | 9 | 153 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Endomyocardial Fibrosis | 9.39e-04 | 9 | 153 | 2 | C0553980 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 9.77e-04 | 145 | 153 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | hypertension | 1.15e-03 | 307 | 153 | 7 | EFO_0000537 | |
| Disease | cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0006937, EFO_0006939, EFO_0006940 | |
| Disease | triacylglycerol 54:1 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0010419 | |
| Disease | thrombosis (implicated_via_orthology) | 1.17e-03 | 10 | 153 | 2 | DOID:0060903 (implicated_via_orthology) | |
| Disease | Nodular glomerulosclerosis | 1.26e-03 | 41 | 153 | 3 | C0017667 | |
| Disease | Charcot-Marie-Tooth disease | 1.35e-03 | 42 | 153 | 3 | cv:C0007959 | |
| Disease | Diabetic Nephropathy | 1.55e-03 | 44 | 153 | 3 | C0011881 | |
| Disease | waist-hip ratio, body mass index | 1.70e-03 | 12 | 153 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | hearing impairment | 1.72e-03 | 98 | 153 | 4 | C1384666 | |
| Disease | coronary artery disease (is_implicated_in) | 1.85e-03 | 100 | 153 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.01e-03 | 13 | 153 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 2.21e-03 | 105 | 153 | 4 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | sickle cell anemia (is_marker_for) | 2.33e-03 | 14 | 153 | 2 | DOID:10923 (is_marker_for) | |
| Disease | Intellectual Disability | 2.39e-03 | 447 | 153 | 8 | C3714756 | |
| Disease | total lipids in medium LDL | 2.51e-03 | 52 | 153 | 3 | EFO_0022180 | |
| Disease | Ciliopathies | 2.62e-03 | 110 | 153 | 4 | C4277690 | |
| Disease | lipoprotein A measurement | 2.80e-03 | 112 | 153 | 4 | EFO_0006925 | |
| Disease | physical activity measurement, body mass index | 2.98e-03 | 114 | 153 | 4 | EFO_0004340, EFO_0008002 | |
| Disease | Seasonal Affective Disorder | 3.06e-03 | 16 | 153 | 2 | C0085159 | |
| Disease | central nervous system disease (implicated_via_orthology) | 3.06e-03 | 16 | 153 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | open-angle glaucoma | 3.26e-03 | 191 | 153 | 5 | EFO_0004190 | |
| Disease | allergic rhinitis (is_marker_for) | 3.45e-03 | 17 | 153 | 2 | DOID:4481 (is_marker_for) | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 3.45e-03 | 17 | 153 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Moyamoya Disease | 3.45e-03 | 17 | 153 | 2 | C0026654 | |
| Disease | sugar consumption measurement | 3.58e-03 | 120 | 153 | 4 | EFO_0010158 | |
| Disease | phospholipids in VLDL measurement | 3.59e-03 | 59 | 153 | 3 | EFO_0022301 | |
| Disease | Colorectal Carcinoma | 3.73e-03 | 702 | 153 | 10 | C0009402 | |
| Disease | total lipids in VLDL measurement | 3.77e-03 | 60 | 153 | 3 | EFO_0022314 | |
| Disease | Age-related macular degeneration | 3.87e-03 | 18 | 153 | 2 | cv:C0242383 | |
| Disease | free cholesterol in VLDL measurement | 3.95e-03 | 61 | 153 | 3 | EFO_0022276 | |
| Disease | Depressive disorder | 4.07e-03 | 289 | 153 | 6 | C0011581 | |
| Disease | taste liking measurement | 4.24e-03 | 388 | 153 | 7 | EFO_0010155 | |
| Disease | carotid artery disease (is_marker_for) | 4.31e-03 | 19 | 153 | 2 | DOID:3407 (is_marker_for) | |
| Disease | uric acid measurement | 4.68e-03 | 610 | 153 | 9 | EFO_0004761 | |
| Disease | Coronary Arteriosclerosis | 4.72e-03 | 65 | 153 | 3 | C0010054 | |
| Disease | cholesterol in large VLDL measurement | 4.72e-03 | 65 | 153 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 4.72e-03 | 65 | 153 | 3 | EFO_0022230 | |
| Disease | Coronary Artery Disease | 4.72e-03 | 65 | 153 | 3 | C1956346 | |
| Disease | total lipids in very large HDL measurement | 4.93e-03 | 66 | 153 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 4.93e-03 | 66 | 153 | 3 | EFO_0022298 | |
| Disease | Disorder of eye | 5.06e-03 | 212 | 153 | 5 | C0015397 | |
| Disease | bitter alcoholic beverage consumption measurement | 5.16e-03 | 133 | 153 | 4 | EFO_0010092 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQTQPIVESLGFQGG | 186 | Q9UK28 | |
| GNGQYTLLAPTNEAF | 271 | Q15582 | |
| LFPGDINFNVSGLFS | 476 | Q6ZT62 | |
| IAGFFAEPIQGVNGV | 281 | Q9BYV1 | |
| FQIVFEATLGGQPAL | 1106 | Q6UXC1 | |
| FSLQLCGAGFPLNQS | 211 | P56817 | |
| PIGLDNVATYAGQFN | 36 | P50995 | |
| YLAELLQGGQSPFQA | 1011 | Q2NKJ3 | |
| GGVFELQPGASVFVN | 226 | P29965 | |
| EQFFQGNFPGSVQRE | 2186 | P78363 | |
| GLDFADPQGSTIFQI | 206 | Q9NP70 | |
| AFLNQGQGLAAPVNA | 166 | Q8NDY6 | |
| RNVNFSGIAGNPVTF | 451 | Q14833 | |
| DGIFFLNPITGVFNL | 1886 | Q6V0I7 | |
| DTLFPGDINFNVSGL | 466 | Q9Y3L3 | |
| IPASGFALFGANQSE | 2041 | Q8WXG9 | |
| VLANDDGPGVLSFNN | 3066 | Q8WXG9 | |
| NFNPLLVAGGVAVAA | 121 | Q8N111 | |
| QAFSFEAQGGLANIA | 81 | P20036 | |
| AISPFNFTAIGGNLA | 206 | P30038 | |
| QAQVPNIDFEGLFGN | 816 | Q6XZF7 | |
| ELHGFQAPAAQGAFL | 171 | Q5T7M4 | |
| LLLQNGANPNITDFF | 116 | A6QL64 | |
| SLNFGGTPNLSVIFN | 226 | Q99467 | |
| SQIFGQASLIPQLFG | 451 | Q9Y2H0 | |
| AIIQTIGFFGSNLPD | 381 | Q14156 | |
| NEPTQNQFGEGSLFF | 321 | Q9UH62 | |
| KNPLDAFEQGQVFLG | 291 | Q9NPF8 | |
| SQPFDFRGAQIISGQ | 166 | O75355 | |
| GDFQGFALVNPQRNS | 1351 | P98160 | |
| VPEGAQLSFGNFAQL | 1376 | P98160 | |
| GFGPLTDLVFAFANQ | 301 | P10276 | |
| GFGPLTDLVFTFANQ | 301 | P10826 | |
| QQGFVQPSLEATGFI | 381 | Q9H0J4 | |
| GFLSNGIVSELQFAP | 16 | Q8TE59 | |
| TGDQARNFFLQSGLP | 41 | Q9NZM3 | |
| EAAQQAFQGLGPGFS | 146 | Q15011 | |
| IAGNIIQIFPSGFQD | 206 | Q6ZNQ3 | |
| PVQGIANENGGITFF | 746 | Q08999 | |
| LEQELFSGGNTGINF | 146 | O00571 | |
| GFSNFPELQVQLFGV | 16 | P58181 | |
| ALFAVNGFNILVDGG | 51 | P78559 | |
| GFQTFQPSGILLDHQ | 2796 | Q16787 | |
| EFNVNSFGPEGQTAL | 41 | Q7Z6K4 | |
| GFFSLDDNVPGLSQL | 46 | Q4VC12 | |
| LNCQGSGFAPVFLQF | 1461 | Q86WG5 | |
| LPNNSLGFILADAGF | 111 | Q5VYY2 | |
| AFLQSLEGAVGAQAP | 551 | Q86U10 | |
| ANVFITLFGENGLSP | 61 | Q8IVV2 | |
| TAIRQTFFPGGDQFQ | 26 | Q4VX62 | |
| GANVTGFQLVDFNTP | 256 | P48058 | |
| FFQILSQNGAPQADV | 96 | P56645 | |
| PDEFGFVFNNVQSLL | 1116 | O75051 | |
| GGSQNILVPLANTAF | 766 | Q9Y4D7 | |
| GFPLLAEDFGQALEQ | 671 | Q13608 | |
| INFLVNNGGGQFLSP | 101 | Q9BY49 | |
| GLGGAFLEEQLFNPS | 401 | A6NFY4 | |
| NLGSGAFEALVEPVN | 351 | Q9P2S2 | |
| PDGLLLFNSGNGNDF | 951 | Q9P2S2 | |
| PLLTFESQQQQVGGF | 136 | Q8N3J3 | |
| NIIANVEPGAFNNLF | 91 | Q7L985 | |
| IVSAVEPGAFNNLFN | 106 | Q96FE5 | |
| VGGFAEAPLLQQAVQ | 481 | O43301 | |
| GRNGVLPQAFDQFFE | 131 | P31270 | |
| VNNLNLPQVALSFGF | 601 | Q9NVP1 | |
| LGQLFAFIGTNPDQA | 1161 | Q9Y4D8 | |
| DVLPAFNALGQLSSG | 481 | P29728 | |
| NLIIFSPSVEDFGGN | 96 | P39656 | |
| VPGFQGDTLQLAFID | 706 | Q8TAG9 | |
| QNFLNAGSFPEIQGF | 221 | Q14451 | |
| TGNLVFANAGGAPNI | 656 | P14859 | |
| NGGLQPAFSVIFSEI | 721 | P21439 | |
| QGVSALLAFPQSQGE | 191 | Q8TCU5 | |
| AIGAFLKGAEQDNPN | 361 | Q9NVE7 | |
| LDPIGLQSGFLTFGQ | 241 | Q3KR16 | |
| EANLFALGPLVGDNF | 456 | Q9Y236 | |
| DAAGGDFPANLVLQL | 31 | A1L1A6 | |
| GEFVVAIGSPFSLQN | 276 | Q92743 | |
| PSALEALINFAYNGN | 86 | O94889 | |
| PGNFQLDIDISGLIF | 401 | Q9P2K1 | |
| QVFQNEFGVETLGPL | 176 | Q7Z4J2 | |
| FPLFANLNNLGFNEL | 201 | Q9H1K4 | |
| QAINEIGAGPFSQFI | 936 | Q53EP0 | |
| GDQARNFFFQSGLPQ | 41 | Q15811 | |
| LFDGSANLVGQFPVV | 841 | P12111 | |
| FDIATLQNPDGINGF | 676 | P55287 | |
| AAQPFLLRNGANEGF | 386 | Q9BYF1 | |
| DSLQAFFPGLQVLIG | 436 | Q92611 | |
| FLPEGQDIGAFVAEQ | 1406 | Q04637 | |
| SPLNQFLAGAAAGAI | 91 | Q8N8R3 | |
| GIFFTDLNGFQVQPR | 896 | P49641 | |
| PSNAIGIANFAEQIG | 181 | Q14145 | |
| FLGQGQVPLNPFSFT | 186 | Q1W209 | |
| GFLGAVVGANFPNNI | 11 | P42261 | |
| NFGVIVLAFPCNQFG | 91 | P59796 | |
| CPVQGVFESFNLDGL | 761 | P21817 | |
| SLGVPVDALFFIGNQ | 276 | Q9Y597 | |
| GAGNSVFPILNTLEN | 206 | Q9H825 | |
| QPFLNALGAAGNFSV | 256 | Q96S52 | |
| SGFVFNLNPLNSSQG | 941 | P11717 | |
| GNLLFLGGSEEQNFT | 3721 | O75445 | |
| PQELDQGTGAALCFF | 211 | Q13671 | |
| FNADETGVFFQLLPQ | 176 | Q17RP2 | |
| DFEGIQGAFAQPQVS | 1111 | Q8IWB6 | |
| NAGPDTNGSQFFITL | 136 | P45877 | |
| VAEGFDFANGINISP | 216 | P27169 | |
| VGSFDIAGLLNNPGF | 216 | O43765 | |
| GEGQLQNIPIDFTNF | 881 | Q8N3T6 | |
| FLEVSLGQFASQGPV | 246 | Q9Y345 | |
| RNQISFISPGAFNGL | 326 | Q8TF66 | |
| AQPQAGLSQANFTLG | 271 | Q8NHL6 | |
| GINATFANIAGALAP | 471 | Q8IVM8 | |
| DALLFGNFGVQNITA | 151 | Q5TEA6 | |
| FVALSPQGTAQGELF | 831 | Q14697 | |
| QGAVQVADGLTLPQF | 201 | P23415 | |
| QGKLPFAAAQIGNSF | 316 | P41250 | |
| NLQLAPTQGAVFVGF | 471 | Q9H3S1 | |
| ANSQFLNGSIGFSPL | 491 | Q9UIU6 | |
| QGFDNPQVRFFLGDL | 71 | Q15738 | |
| QSGEAGAGQLLFANF | 6 | Q9Y4P8 | |
| PEVQVLNVSGRGNFF | 501 | P08F94 | |
| ASQIQGFFDIPVDNL | 131 | P21108 | |
| SLQQLDPENTGFIGA | 76 | O75783 | |
| FLQQSNPGLNFGSVQ | 566 | O15516 | |
| AQSGQASPLLQYFGI | 406 | P53675 | |
| GSSFFGELFNQNPEV | 176 | Q9Y4C5 | |
| LFDFQGDPAQQGGTL | 166 | Q7RTV5 | |
| TFIGFHLQPNINGSV | 2316 | Q63HN8 | |
| NGVQIFFVNPAGEVS | 226 | Q8N0X7 | |
| GLNVQFGALEFGSEP | 531 | Q5T6F2 | |
| ALQNAIAGDPASFIG | 3196 | Q86UP3 | |
| ETATIGFINNFGQIP | 2951 | Q8IZQ1 | |
| ISGLNLQFGALQFGS | 511 | Q14157 | |
| FNGALAAVPVQDLGS | 21 | Q9BWD1 | |
| FVNTLQRQSNGIFPG | 371 | Q9UBZ9 | |
| IDNNPFAKGFRDTGN | 276 | Q13207 | |
| IFGPEVGQASFFNLT | 126 | O95235 | |
| NLEGYVGFANLPNQV | 26 | Q16181 | |
| SGGLQNFLLPQNQFA | 161 | A6NEH6 | |
| GVLPDIEQFFNIGDS | 81 | Q9H2V7 | |
| ASQIQGFFDIPVDNL | 131 | P11908 | |
| AAQEQFGGNPFASLV | 286 | Q9UMX0 | |
| NPFQEAIVFVVGGGN | 586 | Q8WVM8 | |
| PVIRNGGSNTLNFQF | 36 | O60504 | |
| LGDFNFAGIQQANPI | 451 | Q9NZM6 | |
| NGFDPLFNAITGLNG | 21 | O95347 | |
| QLAVLVNDSDFQGPG | 371 | P07949 | |
| QQGPIAFDNVEGLFF | 666 | Q9C026 | |
| NAIPFIGFGFLDNAI | 121 | Q6PI78 | |
| QQLNPGFQLSFASSG | 61 | O95789 | |
| ASQIQGFFDIPVDNL | 131 | P60891 | |
| AFGILVGNNFAPNII | 381 | Q9C0K1 | |
| VGNNFAPNIIFALAG | 386 | Q9C0K1 | |
| QEGDQLNFFPAVDRG | 146 | Q86XD8 | |
| DPQVNAFAIFIGSLG | 1851 | A3KMH1 | |
| TLPQNFGNIFLGETF | 66 | A5PLN9 | |
| LAAFLGGILVFGENN | 106 | Q9Y6I8 | |
| FLVNVGQFNLSGALG | 476 | P01266 | |
| QIQGPLTFGDVAVAF | 6 | Q8NCK3 | |
| LNAVQEQFGGNPFAT | 266 | Q9H347 | |
| FGGAAVFPNQEQARE | 236 | P19971 | |
| PQNLAISIFFRNGTG | 236 | Q08ET2 |